FDA Authorizes Updated COVID Boosters to Target Newest Variants

FDA Authorizes Updated COVID Boosters to Target Newest Variants

Aug. 31, 2022 – The FDA on Wednesday granted emergency use authorization to Omicron-specific COVID-19 vaccines made by Pfizer/BioNTech and Moderna. The agency cited data to support the safety and efficacy of this next generation of mRNA vaccines targeted toward variants of concern. If you’ve been waiting to get a variant-specific booster shot, you may … Read more

Moderna Booster Increases Protection Against Omicron, Company Says

Moderna on Monday announced that a booster dose of its COVID-19 vaccine increased levels of antibodies that fight the Omicron variant. Source link

Pfizer Plans to Seek Booster Approval for 16- and 17-Year-Olds

Nov. 30, 2021 — Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds. “We expect to share updates on this soon,” Kit Longley, a Pfizer spokesman, told The Washington Post. The FDA could authorize the extra dose within a week. If approved, the additional … Read more